Health Care [ 9/12 ] | Life Sciences Tools & Services [ 56/73 ]
NASDAQ | Common Stock
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome.
The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.
It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes.
The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018.
Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 6, 25 | -0.33 Increased by +5.71% | -0.36 Increased by +8.33% |
| Jun 12, 25 | -0.34 Decreased by -6.25% | -0.30 Decreased by -13.33% |
| Feb 26, 25 | -0.37 Decreased by -32.14% | -0.39 Increased by +4.42% |
| Nov 6, 24 | -0.35 Decreased by -6.06% | -0.31 Decreased by -12.90% |
| Aug 8, 24 | -0.35 Increased by +5.41% | -0.36 Increased by +2.78% |
| May 8, 24 | -0.32 Increased by +15.79% | -0.30 Decreased by -6.67% |
| Feb 29, 24 | -0.28 Increased by +22.22% | -0.37 Increased by +24.32% |
| Nov 7, 23 | -0.33 Increased by +13.16% | -0.40 Increased by +17.50% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 4.05 M Increased by +31.87% | -19.42 M Increased by +14.99% | Decreased by -479.49% Increased by +35.54% |
| Mar 31, 25 | 4.21 M Increased by +37.15% | -19.95 M Increased by +3.53% | Decreased by -474.39% Increased by +29.66% |
| Dec 31, 24 | 3.95 M Decreased by -5.53% | -21.74 M Decreased by -22.15% | Decreased by -550.57% Decreased by -29.30% |
| Sep 30, 24 | 3.94 M Increased by +3.36% | -21.33 M Decreased by -1.14% | Decreased by -541.05% Increased by +2.15% |
| Jun 30, 24 | 3.07 M Decreased by -11.47% | -22.85 M Increased by +2.48% | Decreased by -743.82% Decreased by -10.15% |
| Mar 31, 24 | 3.07 M Decreased by -17.54% | -20.68 M Decreased by -1.01% | Decreased by -674.46% Decreased by -22.49% |
| Dec 31, 23 | 4.18 M Increased by +8.32% | -17.80 M Increased by +9.86% | Decreased by -425.81% Increased by +16.79% |
| Sep 30, 23 | 3.81 M Decreased by -3.57% | -21.09 M Increased by +7.89% | Decreased by -552.91% Increased by +4.48% |